SCHEMBL23048776

SCHEMBL23048776

CN1CCC(N(C)c2cc(C=O)ccn2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WNT1 P04628 3/20 0.42
▸ GSK3B P49841 3/20 0.42
▸ DYRK1A Q13627 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CLK2 P49760 1/20 0.40
▸ CLK3 P49761 1/20 0.40
▸ PROKR1 Q8TCW9 1/20 0.39
▸ HTR2A P28223 10/20 0.39
▸ HTR2C P28335 10/20 0.39
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ACACB O00763 1/20 0.37
▸ PIM1 P11309 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19546613 0.86 POLB (0.42) WNT1GSK3BDYRK1APOLBMEN1
SCHEMBL23048678 0.84 POLB (0.40) WNT1GSK3BDYRK1APOLBMEN1
SCHEMBL20951950 0.77 KDM2B (0.53) WNT1GSK3BDYRK1APOLBMEN1
SCHEMBL23048644 0.76 WNT1 (0.47) WNT1GSK3BDYRK1APOLBMEN1
SCHEMBL29119703 0.76 HCRTR2 (0.46) WNT1GSK3BDYRK1APOLBMEN1
SCHEMBL8630443 0.74 ALDH1A1 (0.47) PROKR1HTR2AHTR2CL3MBTL1ALDH1A1
SCHEMBL4778442 0.72 CYP2A6 (0.42) DYRK1AMEN1KMT2APROKR1TSHR
SCHEMBL31601837 0.72 CYP2A6 (0.42) DYRK1AMEN1KMT2APROKR1TSHR
SCHEMBL23048797 0.71 OPRD1 (0.46) WNT1GSK3BDYRK1ACLK2CLK3
SCHEMBL23048583 0.71 WNT1 (0.41) WNT1GSK3BDYRK1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3448386-B1 ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF SAMUMED LLC (US) 2021-03-03 — — EP disclosed
Send feedback